The Quigley Corporation to Announce Second Quarter Results and Host Audi... ( DOYLESTOWN Pa. July 30 /-...)

The Quigley Corporation to Announce Second Quarter Results and Host Audio Web Cast

Date:7/30/2009

DOYLESTOWN, Pa., July 30 /PRNewswire-FirstCall/ -- The Quigley Corporation, (Nasdaq: QGLY), www.quigleyco.com today announced it will issue its second quarter results before market open on Wednesday, August 5, 2009.

Ted Karkus, Chairman and CEO, will provide a Company overview including a review of recent activities and second quarter results on a conference call which will be web cast on The Quigley Corporation's web site, (www.quigleyco.com), at 10:00 AM (ET) that morning.

A replay of the conference call will be available for 30 days on the Company web site.

About The Quigley Corporation

The Quigley Corporation (Nasdaq: QGLY) (http://www.Quigleyco.com) is a diversified natural health medical science company. Its Cold Remedy segment is a leading marketer and manufacturer of the COLD-EEZE(R) family of lozenges, gums and sugar free tablets clinically proven to significantly reduce the severity and duration of the common cold. COLD-EEZE customers include leading national wholesalers and distributors, as well as independent and chain food, drug and mass merchandise stores and pharmacies. The Quigley Corporation has several wholly owned subsidiaries including Quigley Manufacturing Inc., which consists of an FDA approved facility to manufacture COLD-EEZE(R) lozenges and fulfill other contract manufacturing opportunities, and Quigley Pharma Inc., (
'/>"/>

0

GOOD

Page: 1 2
Related medicine news :

1. Quigley Corporation Announces Final Results of Quigley Pharmas Phase IIb Study
2. Ted Karkus Named CEO of The Quigley Corporation; Robert V. Cuddihy, Jr. Named Chief Operating Officer
3. Dr. Richard Rosenbloom Resumes Services To The Quigley Corporations Pharma Subsidiary
4. Ted Karkus Appointed Interim Chief Executive Officer Of The Quigley Corporation
5. Ted Karkus and Karkus Slate of Directors Prevail in Federal Court, Seated as Directors of The Quigley Corporation; Ted Karkus Elected Chairman of the Board
6. The Quigley Corporation Announces Final Voting Results for 2009 Annual Meeting of Shareholders; Judge Orders Incumbent Board to Remain In Place Until Further Hearing; Final Outcome of Director Election Remains Uncertain
7. Dissident Stockholder Ted Karkus Found to Have Undisclosed Financial Arrangements With Dr. Richard A. Rosenbloom, COO Of Quigley Pharma, From 2008 to Date of Proxy: Rosenbloom Suspended Without Pay Pending Further Investigation
8. Karkus Nominees Caution Quigley Shareholders Not to be Fooled by the Companys Latest Announcement
9. The Quigley Corporation Announces Update on Strategic Alternatives and Commitment to Additional Review of Current Cost Structure
10. Judge Rejects Quigleys Claims - Karkus Director Candidates Prevail in Federal Court
11. Quigley Corporation Receives Support from Leading Independent Proxy Advisory Firms; RiskMetrics and Glass Lewis Reject Dissident Stockholder Ted Karkus, Citing Failure to Provide Detailed Business Plan

Post Your Comments:

The Quigley Corporation to Announce Second Quarter Results and Host Audi...( DOYLESTOWN Pa. July 30 /-...),Health